Loading data for IRIX — first visit, this takes a few seconds.
IRIDEX Corporation (IRIX)
NasdaqCM: IRIX
· Real-Time Price · USD
0.96
+0.08 (9.09%)
At close: Aug 18, 2026, 8:00 PM
IRIDEX Corporation (IRIX) Stock Price, Analysis & Data
9.09% (1D)
No data available
| Bid | 0.62 |
| Market Cap | 16.19M |
| Revenue (ttm) | 52.58M |
| Net Income (ttm) | -3.27M |
| Beta | 0.64 |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | n/a |
| Forward PE | 46.51 |
| P/B (ttm) | -12.74 |
| P/S (ttm) | 0.31 |
| Earnings Date | Mar 26, 2026 |
| Ask | 1.13 |
| Volume | 48,807 |
| Avg. Volume (20D) | 57,741 |
| Open | 0.91 |
| Previous Close | 0.88 |
| Day's Range | 0.90 - 0.96 |
| 52-Week Range | 0.80 - 1.65 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IRIX
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, ...
Industry Medical Devices
Sector Healthcare
IPO Date Feb 16, 1996
Employees 93
Stock Exchange NasdaqCM
Ticker Symbol IRIX
Website https://www.iridex.com
Financial Performance
In 2025, IRIDEX's revenue was 52.67M, an increase of 8.23% compared to the previous year's 48.67M. Earnings were -4.44M, a decrease of -50.2%.
Financial StatementsEarnings Surprise
IRIDEX has released their quarterly earnings on May 19, 2026:
IRIDEX Corporation is scheduled to release its earnings on Mar 26, 2026, after market closes.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2